Aurora Cannabis Finalizes Acquisition of CanniMed Therapeutics | CashCropToday
0 Shares 132 Views

Aurora Cannabis Finalizes Acquisition of CanniMed Therapeutics

March 28, 2018
132 Views

Aurora Cannabis (TSX: ACB) (OTCQB: ACBFF) announced this morning that the company has finalized acquisition of 95% of CanniMed Therapeutics (TSX: CMED) outstanding shares to complete “the largest acquisition in cannabis industry history.” Aurora Cannabis plans to acquire the remaining of CanniMeds outstanding shares through compulsory share acquisition.

By completing this transaction, Aurora Cannabis has now added to its portfolio a strongly recognized brand in the medicinal cannabis community. The combined company plans to focus on product and technological development, as well as,  expansion to international markets.

CanniMed has been supplying Health Canada with medicinal cannabis for over a decade and has a collection of over 5,000 physicians referring its cannabis products to patients. Aurora Cannabis believes thats, “CanniMed produces and distributes the most physician-prescribed cannabis oil in the Canadian medical cannabis system.”

The combined company will focus on obtaining EU GMP certification for all of its current and future facilities in an attempt to capture significant market share on the continent of Europe. Aurora Cannabis now has the ability to produce over 280,000 kg of cannabis per year.

Terry Booth, CEO of Aurora Cannabis, stated, ” We believe that our combined assets, capabilities, and brand strength, as well as our consistent execution, position us very well to gain significant share of the global market.”

You may be interested

Aphria Inc. to Expand into Latin America with Proposed $193M Stock Acquisition of LATAM Holdings
Market Watch
64 views
Market Watch
64 views

Aphria Inc. to Expand into Latin America with Proposed $193M Stock Acquisition of LATAM Holdings

Editor - July 17, 2018

Aphria Inc. (TSX: APH) (OTC: APHQF) announced this morning that the company has entered into a share purchase agreement with private company Scythian Biosciences, Inc. (TSXV: SCYB)…

Maricann Obtains Cannabis Manufacturing License in Malta
Market Watch
63 views
Market Watch
63 views

Maricann Obtains Cannabis Manufacturing License in Malta

Editor - July 17, 2018

The Maricann Group (CSE: MARI) (OTCQB:MRRCF), a publicly traded cannabis company with operations in Canada and Germany, announced this morning that their application to for a cannabis manufacturing…

CCT Featured Interview with Ralph Risch Phylos Chief Operating Officer
Tech
105 views
Tech
105 views

CCT Featured Interview with Ralph Risch Phylos Chief Operating Officer

Editor - July 17, 2018

Ralph Risch, COO, of Phylos is an experienced entrepreneur and business leader who has founded and successfully exited multiple companies in the high tech industry. He has…

Leave a Comment

Your email address will not be published.

Most from this category

%d bloggers like this: